BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25948506)

  • 1. Scientific and Regulatory Policy Committee (SRPC) Points to Consider: Histopathology Evaluation of the Pubertal Development and Thyroid Function Assay (OPPTS 890.1450, OPPTS 890.1500) in Rats to Screen for Endocrine Disruptors.
    Keane KA; Parker GA; Regan KS; Picut C; Dixon D; Creasy D; Giri D; Hukkanen RR
    Toxicol Pathol; 2015 Dec; 43(8):1047-63. PubMed ID: 25948506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key lessons from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 male and female pubertal assays.
    Stump DG; O'Connor JC; Lewis JM; Marty MS
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):43-62. PubMed ID: 24510766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ammonium perchlorate in the endocrine disruptor screening and testing program's male pubertal protocol: ability to detect effects on thyroid endpoints.
    Stoker TE; Ferrell JM; Laws SC; Cooper RL; Buckalew A
    Toxicology; 2006 Nov; 228(1):58-65. PubMed ID: 17011691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.
    Bishop PL; Willett CE
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results.
    Borgert CJ; Mihaich EM; Quill TF; Marty MS; Levine SL; Becker RA
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):397-411. PubMed ID: 21251942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of altered food intake during pubertal development in male and female wistar rats.
    Laws SC; Stoker TE; Ferrell JM; Hotchkiss MG; Cooper RL
    Toxicol Sci; 2007 Nov; 100(1):194-202. PubMed ID: 17728285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program.
    Juberg DR; Borghoff SJ; Becker RA; Casey W; Hartung T; Holsapple MP; Marty MS; Mihaich EM; Van Der Kraak G; Wade MG; Willett CE; Andersen ME; Borgert CJ; Coady KK; Dourson ML; Fowle JR; Gray LE; Lamb JC; Ortego LS; Schug TT; Toole CM; Zorrilla LM; Kroner OL; Patterson J; Rinckel LA; Jones BR
    ALTEX; 2014; 31(1):63-78. PubMed ID: 24114257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture, in the EDSP male and female pubertal protocols.
    Stoker TE; Laws SC; Crofton KM; Hedge JM; Ferrell JM; Cooper RL
    Toxicol Sci; 2004 Mar; 78(1):144-55. PubMed ID: 14999130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.
    Browne P; Noyes PD; Casey WM; Dix DJ
    Environ Health Perspect; 2017 Sep; 125(9):096001. PubMed ID: 28934726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee.
    Stoker TE; Parks LG; Gray LE; Cooper RL
    Crit Rev Toxicol; 2000 Mar; 30(2):197-252. PubMed ID: 10759431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of an integrated testing strategy to the U.S. EPA endocrine disruptor screening program.
    Willett CE; Bishop PL; Sullivan KM
    Toxicol Sci; 2011 Sep; 123(1):15-25. PubMed ID: 21642633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study.
    Paul Friedman K; Papineni S; Marty MS; Yi KD; Goetz AK; Rasoulpour RJ; Kwiatkowski P; Wolf DC; Blacker AM; Peffer RC
    Crit Rev Toxicol; 2016 Oct; 46(9):785-833. PubMed ID: 27347635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorpyrifos: weight of evidence evaluation of potential interaction with the estrogen, androgen, or thyroid pathways.
    Juberg DR; Gehen SC; Coady KK; LeBaron MJ; Kramer VJ; Lu H; Marty MS
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):249-63. PubMed ID: 23524272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of thyroid toxicants in a tier I screening battery and alterations in thyroid endpoints over 28 days of exposure.
    O'Connor JC; Frame SR; Davis LG; Cook JC
    Toxicol Sci; 1999 Sep; 51(1):54-70. PubMed ID: 10496677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hydroxyatrazine in the endocrine disruptor screening and testing program's male and female pubertal protocols.
    Stoker TE; Hallinger DR; Seely JC; Zorrilla LM
    Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):428-35. PubMed ID: 24323408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing utility of thyroid in vitro screening assays through comparisons to observed impacts in vivo.
    Eytcheson SA; Olker JH; Friedman KP; Hornung MW; Degitz SJ
    Regul Toxicol Pharmacol; 2023 Oct; 144():105491. PubMed ID: 37666444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the laboratory rat as a model in endocrine disruptor screening and testing.
    Gray LE; Wilson V; Noriega N; Lambright C; Furr J; Stoker TE; Laws SC; Goldman J; Cooper RL; Foster PM
    ILAR J; 2004; 45(4):425-37. PubMed ID: 15454681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).
    O'Connor JC; Cook JC; Marty MS; Davis LG; Kaplan AM; Carney EW
    Crit Rev Toxicol; 2002; 32(6):521-49. PubMed ID: 12487364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of atrazine on puberty in male wistar rats: an evaluation in the protocol for the assessment of pubertal development and thyroid function.
    Stoker TE; Laws SC; Guidici DL; Cooper RL
    Toxicol Sci; 2000 Nov; 58(1):50-9. PubMed ID: 11053540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.